Does Mounjaro List Dizziness as a Side Effect?
Yes, dizziness is a reported side effect of Mounjaro (tirzepatide), an injectable GLP-1/GIP receptor agonist for type 2 diabetes and weight management. Clinical trials and post-marketing data show it affects 1-5% of users, often linked to low blood sugar (hypoglycemia), dehydration, or gastrointestinal issues like nausea and vomiting that lead to volume depletion.[1][2]
How Common Is Dizziness and When Does It Happen?
Dizziness occurs more frequently early in treatment or after dose increases (e.g., from 2.5 mg to 5 mg weekly). In SURMOUNT trials for obesity, about 4% of participants reported it, versus 2% on placebo. It's usually mild and transient, resolving as the body adjusts, but severe cases can signal hypoglycemia—especially if combined with insulin or sulfonylureas.[1][3]
Why Does Mounjaro Cause Dizziness?
Primary mechanisms include:
- Hypoglycemia: Tirzepatide lowers blood glucose, sometimes too much, impairing brain function and causing lightheadedness.
- Dehydration/GI effects: Nausea (up to 20%), vomiting (up to 10%), and diarrhea reduce fluid intake, dropping blood pressure.
- Blood pressure changes: Some users experience orthostatic hypotension, where standing quickly triggers dizziness.[2][4]
What Should You Do If You Feel Dizzy on Mounjaro?
Monitor blood sugar if diabetic. Drink fluids, eat small meals, and rise slowly from sitting/lying. Contact a doctor if dizziness persists, worsens, or includes fainting, confusion, or vision changes—these could indicate serious issues like severe hypoglycemia or pancreatitis. Dose adjustments or anti-nausea meds help many.[1][5]
How Does Dizziness Compare to Other GLP-1 Drugs Like Ozempic or Wegovy?
Similar profile: Ozempic (semaglutide) reports dizziness in 3-8% of users, often from the same causes. Wegovy has comparable rates. Mounjaro may edge higher due to dual GLP-1/GIP action amplifying GI effects, but head-to-head data is limited.[2][3]
Who Is at Higher Risk for Dizziness?